FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US6841617B2
(en)
*
|
2000-09-28 |
2005-01-11 |
Battelle Memorial Institute |
Thermogelling biodegradable aqueous polymer solution
|
US6451346B1
(en)
*
|
1998-12-23 |
2002-09-17 |
Amgen Inc |
Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
|
EP1173151B1
(fr)
|
1999-04-16 |
2003-07-09 |
Novo Nordisk A/S |
Formulation pharmaceutique seche et moulable
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
US6998137B2
(en)
*
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
CA2405709A1
(fr)
*
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Proteines fusionnees a l'albumine
|
US6723814B2
(en)
*
|
2000-05-16 |
2004-04-20 |
Biocure, Inc. |
Amphiphilic copolymer planar membranes
|
EP1315672A4
(fr)
|
2000-06-22 |
2006-04-26 |
Rxkinetix Inc |
Composition de vecteur d'administration et procede pour l'administration d'antigenes et d'autres medicaments
|
DE60127139T2
(de)
*
|
2000-07-14 |
2007-12-13 |
Novo Nordisk A/S |
Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
|
EP1328873A1
(fr)
*
|
2000-08-29 |
2003-07-23 |
Contivo, Inc. |
Groupes virtuels
|
US7666445B2
(en)
*
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
MXPA03004112A
(es)
*
|
2000-11-09 |
2003-08-19 |
Astrazeneca Ab |
Composicion farmaceutica oral que contiene un copolimero de bloque.
|
US20040185101A1
(en)
*
|
2001-03-27 |
2004-09-23 |
Macromed, Incorporated. |
Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
|
FR2822834B1
(fr)
*
|
2001-04-02 |
2005-02-25 |
Flamel Tech Sa |
Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
|
US20030143191A1
(en)
*
|
2001-05-25 |
2003-07-31 |
Adam Bell |
Chemokine beta-1 fusion proteins
|
KR100566911B1
(ko)
*
|
2001-06-25 |
2006-04-03 |
주식회사 삼양사 |
약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
|
US7226616B2
(en)
|
2001-07-14 |
2007-06-05 |
Samyang Corporation |
Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
|
US6592899B2
(en)
|
2001-10-03 |
2003-07-15 |
Macromed Incorporated |
PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
|
US7309498B2
(en)
*
|
2001-10-10 |
2007-12-18 |
Belenkaya Bronislava G |
Biodegradable absorbents and methods of preparation
|
JP2005510521A
(ja)
*
|
2001-11-12 |
2005-04-21 |
アルカーメス コントロールド セラピューティクス,インコーポレイテッド |
生体適合性ポリマーブレンドおよびその使用
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
CA2471363C
(fr)
*
|
2001-12-21 |
2014-02-11 |
Human Genome Sciences, Inc. |
Proteines hybrides d'albumine
|
EP1463752A4
(fr)
*
|
2001-12-21 |
2005-07-13 |
Human Genome Sciences Inc |
Proteines de fusion d'albumine
|
WO2003080629A2
(fr)
*
|
2002-02-25 |
2003-10-02 |
Guilford Pharmaceuticals, Inc. |
Composes contenant du phosphore, a chaines polymeres, et procedes de fabrication et d'utilisation associes
|
ITMI20020865A1
(it)
*
|
2002-04-22 |
2003-10-22 |
Novamont Spa |
Poliesteri biodegradabili ottenuti mediante estrusione reattiva
|
US20030204180A1
(en)
*
|
2002-04-30 |
2003-10-30 |
Kimberly-Clark Worldwide, Inc. |
Temperature responsive delivery systems
|
FR2840614B1
(fr)
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
US7439063B2
(en)
*
|
2002-06-11 |
2008-10-21 |
Burnham Institute For Medical Research |
Neuroprotective synergy of erythropoietin and insulin-like growth factors
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US20030232088A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Kimberly-Clark Worldwide, Inc. |
Materials with both bioadhesive and biodegradable components
|
US7037983B2
(en)
|
2002-06-14 |
2006-05-02 |
Kimberly-Clark Worldwide, Inc. |
Methods of making functional biodegradable polymers
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
FR2843117B1
(fr)
*
|
2002-07-30 |
2004-10-15 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
|
WO2004029129A1
(fr)
*
|
2002-09-24 |
2004-04-08 |
Asahi Kasei Chemicals Corporation |
Copolymere d'acide glycolique et son procede de production
|
MXPA05005038A
(es)
*
|
2002-11-12 |
2005-07-01 |
Teva Pharma |
Composiciones farmaceuticas y formas de dosis para la entrega bucal y sublingual de tizanidina y metodos para administrar tizanidina sublingual o bucalmente.
|
US6992543B2
(en)
*
|
2002-11-22 |
2006-01-31 |
Raytheon Company |
Mems-tuned high power, high efficiency, wide bandwidth power amplifier
|
US7220431B2
(en)
*
|
2002-11-27 |
2007-05-22 |
Regents Of The University Of Minnesota |
Methods and compositions for applying pharmacologic agents to the ear
|
FR2855521B1
(fr)
*
|
2003-05-28 |
2005-08-05 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
|
EP1642921B1
(fr)
*
|
2003-07-07 |
2008-08-27 |
Nof Corporation |
Copolymere tribloc, procede d'elaboration, et materiau biocompatible
|
FR2860516B1
(fr)
*
|
2003-10-03 |
2006-01-13 |
Flamel Tech Sa |
Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
FR2862535B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
|
FR2862536B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
EP1711124A4
(fr)
*
|
2004-01-12 |
2011-06-01 |
Univ Pennsylvania |
Preparations a liberation a long terme et procedes d'utlisation de celles-ci
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
CA2552677A1
(fr)
*
|
2004-01-13 |
2005-07-28 |
Vasogenix Pharmaceuticals, Inc. |
Composition a liberation controlee pour l'administration de cgrp en cas de problemes cardio-vasculaires et renaux
|
EP1703915A2
(fr)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Procedes permettant d'utiliser le cgrp dans des indications cardiovasculaires et renales
|
JP2007517913A
(ja)
*
|
2004-01-13 |
2007-07-05 |
バソジェニックス ファーマシューティカルズ, インコーポレイテッド |
カルシトニン遺伝子関連ペプチドを投与することによって急性心筋梗塞を処置するための方法およびカルシトニン遺伝子関連ペプチドを含有する組成物
|
MXPA06008496A
(es)
|
2004-02-02 |
2007-01-30 |
Ambrx Inc |
Polipeptidos de interferon humano modificados y sus usos.
|
US20060039985A1
(en)
*
|
2004-04-27 |
2006-02-23 |
Bennett David B |
Methotrexate compositions
|
MXPA06014684A
(es)
*
|
2004-06-18 |
2007-02-12 |
Ambrx Inc |
Novedosos polipeptidos de enlace antigeno y sus usos.
|
KR20070039593A
(ko)
*
|
2004-07-21 |
2007-04-12 |
암브룩스, 인코포레이티드 |
비천연적으로 코딩된 아미노산을 이용한 생합성 폴리펩티드
|
WO2009100255A2
(fr)
|
2008-02-08 |
2009-08-13 |
Ambrx, Inc. |
Polypeptides leptine modifiés et leurs utilisations
|
US20060034889A1
(en)
|
2004-08-16 |
2006-02-16 |
Macromed, Inc. |
Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
|
US20060153786A1
(en)
|
2004-12-10 |
2006-07-13 |
Talima Therapeutics, Inc. |
Compositions and methods for treating conditions of the nail unit
|
US20060275230A1
(en)
|
2004-12-10 |
2006-12-07 |
Frank Kochinke |
Compositions and methods for treating conditions of the nail unit
|
ATE541934T1
(de)
*
|
2004-12-22 |
2012-02-15 |
Ambrx Inc |
Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
|
MX2007007580A
(es)
*
|
2004-12-22 |
2007-12-11 |
Ambrx Inc |
Hormona del crecimiento humana modificada.
|
BRPI0518661A2
(pt)
*
|
2004-12-22 |
2008-12-02 |
Ambrx Inc |
mÉtodos para expressço e purificaÇço do hormânio do crescimento humano recombinante
|
KR101224781B1
(ko)
|
2004-12-22 |
2013-01-21 |
암브룩스, 인코포레이티드 |
비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물
|
US8007775B2
(en)
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
US7608612B2
(en)
*
|
2005-01-21 |
2009-10-27 |
Richard H. Matthews |
Radiosensitizer formulations and methods for use
|
WO2006082221A1
(fr)
*
|
2005-02-03 |
2006-08-10 |
Cinvention Ag |
Materiaux de delivrance de medicaments elabores en technologie sol/gel
|
US20060224095A1
(en)
*
|
2005-04-05 |
2006-10-05 |
University Of New Hampshire |
Biocompatible polymeric vesicles self assembled from triblock copolymers
|
EP1893229B1
(fr)
|
2005-06-03 |
2011-10-19 |
Ambrx, Inc. |
Molecules d'interferons humains ameliorees et utilisations de celles-ci
|
DE102005033101A1
(de)
*
|
2005-07-15 |
2007-01-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Resorbierbare Polyetherester und ihre Verwendung zur Herstellung von medizinischen Implantaten
|
US20080247987A1
(en)
*
|
2005-08-04 |
2008-10-09 |
Angiotech International Ag |
Block Copolymer Compositions and Uses Thereof
|
AU2005335491B2
(en)
|
2005-08-18 |
2010-11-25 |
Ambrx, Inc. |
Compositions of tRNA and uses thereof
|
CN1939534B
(zh)
*
|
2005-09-27 |
2010-12-01 |
长春金赛药业股份有限公司 |
含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
US8124128B2
(en)
*
|
2005-11-08 |
2012-02-28 |
Industrial Technology Research Institute |
Amphiphilic block copolymers and nano particles comprising the same
|
AU2006311568B2
(en)
*
|
2005-11-08 |
2010-11-11 |
Ambrx, Inc. |
Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
|
PT2339014E
(pt)
*
|
2005-11-16 |
2015-10-13 |
Ambrx Inc |
Métodos e composições compreendendo aminoácidos não-naturais
|
FR2893943B1
(fr)
*
|
2005-11-28 |
2011-08-19 |
Centre Nat Rech Scient |
Procede de preparation de copolymeres par polymerisation anionique sans solvant
|
US8288477B2
(en)
|
2005-12-06 |
2012-10-16 |
Tyco Healthcare Group Lp |
Bioabsorbable compounds and compositions containing them
|
US20070142287A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Biomed Solutions, Llc |
Compositions And Methods For Treatment Of Cancer
|
US20070154546A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Zhang Jack Y |
Sustained release pharmaceutical compositions
|
KR100784485B1
(ko)
|
2006-01-18 |
2007-12-11 |
한국과학기술연구원 |
생분해성 온도 감응성 폴리포스파젠계 하이드로젤, 그의제조방법 및 그의 용도
|
CN101400717B
(zh)
*
|
2006-03-09 |
2011-08-31 |
科洛普拉斯特公司 |
具有用于软组织再生的改进生物相容性的可降解亲水嵌段共聚物
|
US20070224234A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Mark Steckel |
Medical devices having biodegradable polymeric regions
|
US7740877B2
(en)
|
2006-04-07 |
2010-06-22 |
University Of Utah Research Foundation |
Aliphatically modified biodegradable block copolymers as thermogelling polymers
|
EP2012803A4
(fr)
*
|
2006-04-20 |
2012-08-01 |
Univ Utah Res Found |
Compositions polymères et procédés de production et d'utilisation de ces compositions
|
US8747870B2
(en)
|
2006-04-20 |
2014-06-10 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
US20100119529A1
(en)
*
|
2006-05-12 |
2010-05-13 |
Furgeson Darin Y |
Elastin-like polymer delivery vehicles
|
US7794495B2
(en)
*
|
2006-07-17 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Controlled degradation of stents
|
CA2662753C
(fr)
*
|
2006-09-08 |
2016-02-23 |
Ambrx, Inc. |
Arnt suppresseur hybride pour cellules de vertebres
|
US8420792B2
(en)
|
2006-09-08 |
2013-04-16 |
Ambrx, Inc. |
Suppressor tRNA transcription in vertebrate cells
|
CN106008699A
(zh)
|
2006-09-08 |
2016-10-12 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
JP2008069324A
(ja)
*
|
2006-09-15 |
2008-03-27 |
Mitsui Chemicals Inc |
生分解性を有する水環境応答型ポリマーを含む水崩壊性組成物および水崩壊性成形体
|
AU2007325409B2
(en)
*
|
2006-11-09 |
2013-03-28 |
Alcon Research, Ltd. |
Water insoluble polymer matrix for drug delivery
|
US20080114076A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Alcon Manufacturing Ltd. |
Punctal plug comprising a water-insoluble polymeric matrix
|
CN1965802B
(zh)
*
|
2006-11-09 |
2010-04-14 |
复旦大学 |
一种聚乙二醇化药物的可注射性水凝胶制剂及其制备方法
|
US8871242B2
(en)
*
|
2006-11-17 |
2014-10-28 |
National Cerebral And Cardiovascular Center |
Blood anticoagulant material, coating material and indwelling device comprising the same, and treatment using blood anticoagulant material
|
US20080140106A1
(en)
*
|
2006-12-12 |
2008-06-12 |
Kimberly-Clark Worldwide, Inc. |
Enhanced cuff sealing for endotracheal tubes
|
GB0701896D0
(en)
|
2007-02-01 |
2007-03-14 |
Regentec Ltd |
Composition
|
EP2068909B1
(fr)
|
2007-03-30 |
2012-04-25 |
Ambrx, Inc. |
Polypeptides fgf-21 modifies, et leurs utilisations
|
CN100445313C
(zh)
*
|
2007-04-24 |
2008-12-24 |
上海同杰良生物材料有限公司 |
一种聚乳酸/聚醚二元醇共聚物的制备方法
|
AU2008247815B2
(en)
|
2007-05-02 |
2012-09-06 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
FR2915683B1
(fr)
*
|
2007-05-03 |
2009-08-07 |
Flamel Technologies Sa |
Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
|
EP2155769B1
(fr)
|
2007-05-04 |
2012-06-27 |
Katholieke Universiteit Leuven KU Leuven Research & Development |
Protection contre la dégénérescence tissulaire
|
KR20080110473A
(ko)
|
2007-06-14 |
2008-12-18 |
한국과학기술연구원 |
화학적 가교 결합을 가지는 포스파젠계 고분자 하이드로젤,그의 제조방법 및 그의 용도
|
KR100968591B1
(ko)
*
|
2007-06-14 |
2010-07-08 |
한국과학기술연구원 |
약물전달용 폴리포스파젠계 하이드로젤, 그의 제조방법 및그의 용도
|
US20090004243A1
(en)
|
2007-06-29 |
2009-01-01 |
Pacetti Stephen D |
Biodegradable triblock copolymers for implantable devices
|
JP5171146B2
(ja)
*
|
2007-07-27 |
2013-03-27 |
学校法人 関西大学 |
温度応答性を有する生分解性ポリマー及びその製造方法
|
WO2009042114A2
(fr)
|
2007-09-21 |
2009-04-02 |
The Johns Hopkins University |
Dérivés de phénazine et leurs utilisations
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
JP5547083B2
(ja)
|
2007-11-20 |
2014-07-09 |
アンブルックス,インコーポレイテッド |
修飾されたインスリンポリペプチドおよびそれらの使用
|
RU2459840C2
(ru)
*
|
2007-12-31 |
2012-08-27 |
Самъянг Корпорейшн |
АМФИФИЛЬНЫЙ СОПОЛИМЕР ВЫСОКОЙ ЧИСТОТЫ, СОДЕРЖАЩИЙ ГИДРОФОБНЫЙ БЛОК ИЗ α-ГИДРОКСИКИСЛОТЫ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ
|
US20090183503A1
(en)
*
|
2008-01-18 |
2009-07-23 |
Alberto Verdesi |
Exhaust apparatus
|
WO2009100422A2
(fr)
*
|
2008-02-08 |
2009-08-13 |
Zimmer, Inc. |
Système d'administration de médicament comprenant des microparticules et système de gélification
|
UA90013C2
(ru)
|
2008-03-19 |
2010-03-25 |
Давид Анатолійович Нога |
Фармацевтическая композиция, содержащая инсулин, и способ его получения
|
TWI388591B
(zh)
*
|
2008-03-28 |
2013-03-11 |
Ind Tech Res Inst |
溫度敏感性材料
|
US8916188B2
(en)
|
2008-04-18 |
2014-12-23 |
Abbott Cardiovascular Systems Inc. |
Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
|
US20090285873A1
(en)
*
|
2008-04-18 |
2009-11-19 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices and coatings therefor comprising block copolymers of poly(ethylene glycol) and a poly(lactide-glycolide)
|
US20090297584A1
(en)
*
|
2008-04-18 |
2009-12-03 |
Florencia Lim |
Biosoluble coating with linear over time mass loss
|
US11969501B2
(en)
|
2008-04-21 |
2024-04-30 |
Dompé Farmaceutici S.P.A. |
Auris formulations for treating otic diseases and conditions
|
US9132087B2
(en)
|
2008-04-21 |
2015-09-15 |
Otonomy, Inc. |
Auris formulations for treating otic diseases and conditions
|
KR101534422B1
(ko)
|
2008-05-14 |
2015-07-09 |
오토노미, 인코포레이티드 |
귀 질환 치료를 위한 제어 방출형 코르티코스테로이드 조성물 및 방법
|
US8652506B2
(en)
*
|
2008-06-05 |
2014-02-18 |
Boston Scientific Scimed, Inc. |
Bio-degradable block co-polymers for controlled release
|
EP2309991B1
(fr)
|
2008-06-16 |
2019-03-06 |
Pfizer Inc |
Nanoparticules polymères thérapeutiques comprenant des alcaloïdes vinca et procédés de fabrication et d utilisation associés
|
SI2774608T1
(sl)
|
2008-06-16 |
2020-02-28 |
Pfizer Inc. |
Polimerni nanodelci, napolnjeni z zdravilom, ter postopki za njihovo pripravo in uporabo
|
US8613951B2
(en)
*
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
US8318817B2
(en)
|
2008-07-21 |
2012-11-27 |
Otonomy, Inc. |
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
|
CN102105133B
(zh)
|
2008-07-21 |
2015-06-17 |
奥德纳米有限公司 |
控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法
|
US8784870B2
(en)
*
|
2008-07-21 |
2014-07-22 |
Otonomy, Inc. |
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
|
US10138283B2
(en)
|
2008-07-23 |
2018-11-27 |
Ambrx, Inc. |
Modified bovine G-CSF polypeptides and their uses
|
JP5435534B2
(ja)
*
|
2008-08-27 |
2014-03-05 |
多木化学株式会社 |
生体材料
|
MX348657B
(es)
|
2008-09-26 |
2017-06-21 |
Ambrx Inc |
Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
|
CN107022020A
(zh)
|
2008-09-26 |
2017-08-08 |
Ambrx公司 |
修饰的动物促红细胞生成素多肽和其用途
|
US20100081622A1
(en)
*
|
2008-09-29 |
2010-04-01 |
Sanos Bioscience A/S |
Reduction of parathyroid hormone levels
|
WO2010053993A1
(fr)
|
2008-11-04 |
2010-05-14 |
The Trustees Of Columbia University In The City Of New York |
Polymères hétérobifonctionnels et procédés de construction de films multicouches par superposition des couches
|
WO2010068866A2
(fr)
|
2008-12-12 |
2010-06-17 |
Bind Biosciences |
Particules thérapeutiques pour administration parentérale, et procédés de fabrication et d'utilisation associés
|
EP2379064B1
(fr)
|
2008-12-15 |
2020-02-26 |
Pfizer Inc. |
Longues nanoparticules circulantes pour la libération prolongée d'agents thérapeutiques
|
TWI374903B
(en)
*
|
2008-12-31 |
2012-10-21 |
Ind Tech Res Inst |
Biodegradable copolymer hydrogel materials
|
US9200112B2
(en)
|
2009-08-10 |
2015-12-01 |
Ethicon, Inc. |
Semi-crystalline, fast absorbing polymer formulation
|
KR101838303B1
(ko)
*
|
2009-09-18 |
2018-03-13 |
비티지 인터내셔널 리미티드 |
재구성가능한 가역적 열 겔화 고분자
|
WO2011035264A1
(fr)
|
2009-09-18 |
2011-03-24 |
Protherics Salt Lake City, Inc. |
Polymères triblocs bab à caractéristiques améliorées de libération
|
US8753621B2
(en)
*
|
2009-09-18 |
2014-06-17 |
Protherics Salt Lake City, Inc. |
BAB triblock polymers having improved release characteristics
|
US9155722B2
(en)
*
|
2009-09-18 |
2015-10-13 |
Protherics Salt Lake City, Inc. |
Reconstitutable reverse thermal gelling polymers
|
WO2011049958A2
(fr)
|
2009-10-21 |
2011-04-28 |
Otonomy, Inc. |
Modulation de la température de gélification de formulations contenant des poloxamères
|
US9044524B2
(en)
|
2009-10-30 |
2015-06-02 |
Ethicon, Inc. |
Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants
|
EP2509634B1
(fr)
|
2009-12-11 |
2019-03-06 |
Pfizer Inc |
Formulations stables pour particules thérapeutiques de lyophilisation
|
US9295649B2
(en)
|
2009-12-15 |
2016-03-29 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
|
CA2784800A1
(fr)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Polypeptides d'hormone de croissance porcine modifiee et leurs utilisations
|
AU2010341516B2
(en)
|
2009-12-21 |
2014-01-16 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
JP2013516485A
(ja)
|
2010-01-07 |
2013-05-13 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
耳にモキシフロキサシンを適用するための方法および組成物
|
EP2343046A1
(fr)
|
2010-01-08 |
2011-07-13 |
Nirvana's Tree House B.V. |
Copolymères triblocs fonctionnalisés et compositions contenant lesdits polymères
|
US8551531B2
(en)
|
2010-04-12 |
2013-10-08 |
The Curators Of The University Of Missouri |
Pentablock polymers
|
EP2380920A1
(fr)
*
|
2010-04-22 |
2011-10-26 |
QGel SA |
Formulation de précurseur d'hydrogel et son procédé de fabrication
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
SG10201506443TA
(en)
|
2010-08-17 |
2015-10-29 |
Ambrx Inc |
Modified relaxin polypeptides and their uses
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
EA201390600A1
(ru)
*
|
2010-10-22 |
2013-09-30 |
Байнд Терапьютикс, Инк. |
Терапевтические наночастицы с сополимерами с большим молекулярным весом
|
US20120164100A1
(en)
*
|
2010-11-02 |
2012-06-28 |
Ren-Ke Li |
Temperature sensitive hydrogel and block copolymers
|
WO2012061907A2
(fr)
|
2010-11-10 |
2012-05-18 |
Katholieke Universiteit Leuven |
Activité des ostéoclastes
|
CN103380237A
(zh)
*
|
2010-12-15 |
2013-10-30 |
3M创新有限公司 |
可降解的纤维
|
US9006345B2
(en)
|
2011-03-25 |
2015-04-14 |
The Trustees Of Columbia University In The City Of New York |
Heterotrifunctional molecules and methods for the synthesis of dendrimeric materials
|
WO2012131106A1
(fr)
|
2011-03-31 |
2012-10-04 |
Ingell Technologies Holding B.V. |
Compositions biodégradables appropriées pour une libération contrôlée
|
ES2820369T3
(es)
|
2011-03-31 |
2021-04-20 |
Ingell Tech Holding B V |
Composiciones biodegradables adecuadas para liberación controlada
|
GB201105455D0
(en)
*
|
2011-03-31 |
2011-05-18 |
British American Tobacco Co |
Blends of a polylactic acid and a water soluble polymer
|
US8586020B2
(en)
|
2011-06-30 |
2013-11-19 |
Korea Institute Of Science And Technology |
Poly(organophosphazene) composition for biomaterials
|
WO2013055331A1
(fr)
*
|
2011-10-12 |
2013-04-18 |
The Curators Of The University Of Missouri |
Polymères pentablocs
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
HRP20211377T1
(hr)
|
2011-11-23 |
2022-01-07 |
Therapeuticsmd, Inc. |
Prirodne kombinirane hormonske supstitucijske formulacije i terapije
|
WO2013090652A1
(fr)
*
|
2011-12-16 |
2013-06-20 |
Natureworks Llc |
Fibres de polylactide
|
US9422387B2
(en)
*
|
2012-03-30 |
2016-08-23 |
Kimberly-Clark Worldwide, Inc. |
Dual responsive block copolymer compositions
|
CN102786675B
(zh)
*
|
2012-05-23 |
2014-04-30 |
上海交通大学 |
一种嵌段高分子及其合成方法和纳米颗粒的制备方法
|
CN103656679B
(zh)
*
|
2012-05-23 |
2016-02-10 |
上海交通大学 |
一种纳米颗粒的制备方法
|
SG11201408161RA
(en)
|
2012-06-08 |
2015-01-29 |
Sutro Biopharma Inc |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
ES2611788T3
(es)
|
2012-06-26 |
2017-05-10 |
Sutro Biopharma, Inc. |
Proteínas de Fc modificadas que comprenden residuos de aminoácidos no naturales específicos del sitio, conjugados de las mismas, métodos para su preparación y métodos para su uso
|
SI3584255T1
(sl)
|
2012-08-31 |
2022-05-31 |
Sutro Biopharma, Inc |
Modificirane aminokisline, ki vsebujejo azido skupino
|
MX356097B
(es)
|
2012-09-17 |
2018-05-14 |
Pfizer Inc Star |
Proceso para la preparacion de nanoparticulas terapeuticas.
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
RU2015143995A
(ru)
|
2013-03-14 |
2017-04-20 |
Халлюкс, Инк. |
Способ лечения инфекций, заболеваний или расстройств ногтевого ложа
|
EP2996683B1
(fr)
|
2013-05-16 |
2018-04-18 |
The Curators of the University of Missouri |
Polymères pentaséquencés utilisés comme vecteurs de médicament
|
WO2015006555A2
(fr)
|
2013-07-10 |
2015-01-15 |
Sutro Biopharma, Inc. |
Anticorps comprenant plusieurs résidus d'acides aminés non naturels site-spécifiques, des procédés permettant leur préparation et leurs méthodes d'utilisation
|
US10682415B2
(en)
*
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
WO2015031393A1
(fr)
|
2013-08-27 |
2015-03-05 |
Otonomy, Inc. |
Méthodes pour le traitement de troubles otiques chez les enfants
|
US9840493B2
(en)
|
2013-10-11 |
2017-12-12 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
US10364141B2
(en)
*
|
2013-12-23 |
2019-07-30 |
Washington State University |
Block copolymer nanostructures formed by disturbed self-assembly and uses thereof
|
CN103819905B
(zh)
*
|
2014-03-07 |
2016-01-20 |
山东理工大学 |
一种用聚三亚甲基碳酸酯与聚乙烯吡咯烷酮对聚肽膜亲水性进行改进的方法
|
BR112016021130A2
(pt)
|
2014-03-14 |
2017-08-15 |
Pfizer |
Nanopartículas terapêuticas, composição farmacêutica compreendendo as referidas nanopartículas, processo para a preparação e uso das mesmas
|
CA2947767A1
(fr)
|
2014-05-22 |
2015-11-26 |
Therapeuticsmd, Inc. |
Formulations d'hormones substitutives combinees naturelles et traitement hormonal substitutif
|
KR20170021353A
(ko)
|
2014-07-03 |
2017-02-27 |
오토노미, 인코포레이티드 |
시프로플록사신 조성물의 멸균
|
KR101570849B1
(ko)
|
2014-08-18 |
2015-11-20 |
성균관대학교산학협력단 |
온도감응형 이온성 복합체, 이의 제조 방법, 및 이를 포함하는 생분해성 조성물
|
LT3412302T
(lt)
|
2014-10-24 |
2021-07-26 |
Bristol-Myers Squibb Company |
Modifikuoti fgf-21 polipeptidai ir jų panaudojimai
|
WO2016100380A1
(fr)
|
2014-12-15 |
2016-06-23 |
The Johns Hopkins University |
Formulations de sunitinib et méthodes d'utilisation de ces dernières dans le traitement du glaucome
|
US9375478B1
(en)
|
2015-01-30 |
2016-06-28 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9925233B2
(en)
|
2015-01-30 |
2018-03-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
CN104645356B
(zh)
*
|
2015-01-30 |
2018-11-13 |
复旦大学 |
一类x射线显影的热致水凝胶及其制备方法
|
US9937223B2
(en)
|
2015-01-30 |
2018-04-10 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9750785B2
(en)
|
2015-01-30 |
2017-09-05 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9744209B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9687526B2
(en)
|
2015-01-30 |
2017-06-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
KR20180037994A
(ko)
|
2015-07-28 |
2018-04-13 |
오토노미, 인코포레이티드 |
TrkB 또는 TrkC 아고니스트 조성물 및 귀 병태의 치료 방법
|
CN105062021B
(zh)
*
|
2015-08-18 |
2017-03-01 |
九江学院 |
一种非温敏可降解聚合物胶乳及其制备方法
|
KR20180102069A
(ko)
|
2015-11-12 |
2018-09-14 |
그레이버그 비젼, 인크. |
요법을 위한 응집성 마이크로입자
|
US11246863B2
(en)
|
2015-12-11 |
2022-02-15 |
Alk-Abelló, Inc. |
Ciprofloxacin otic composition and kits and method for using same
|
JP2019513709A
(ja)
|
2016-04-01 |
2019-05-30 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
ステロイドホルモン薬学的組成物
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
WO2018053173A1
(fr)
|
2016-09-16 |
2018-03-22 |
Otonomy, Inc. |
Formulations de gel otique pour le traitement de l'otite externe
|
US9987369B2
(en)
|
2016-11-01 |
2018-06-05 |
International Business Machines Corporation |
Vitamin functionalized gel-forming block copolymers for biomedical applications
|
US10266578B2
(en)
|
2017-02-08 |
2019-04-23 |
Bristol-Myers Squibb Company |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
CN110662543A
(zh)
|
2017-03-23 |
2020-01-07 |
灰色视觉公司 |
用于治疗眼部疾病的药物和组合物
|
US11911532B2
(en)
|
2017-03-29 |
2024-02-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Reverse thermal gels and their use as vascular embolic repair agents
|
MX2019013363A
(es)
|
2017-05-10 |
2020-01-13 |
Graybug Vision Inc |
Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica.
|
WO2019154895A1
(fr)
|
2018-02-08 |
2019-08-15 |
Strekin Ag |
Formulation en gel pour la prévention ou le traitement de la perte auditive
|
CN108250415B
(zh)
*
|
2018-02-09 |
2020-09-04 |
青岛科技大学 |
一种聚(γ-丁内酯)-b-聚乳酸嵌段共聚物及其制备方法
|
CA3111576A1
(fr)
|
2018-09-11 |
2020-03-19 |
Ambrx, Inc. |
Conjugues polypeptidiques d'interleukine-2 et leurs utilisations
|
EP3867265A1
(fr)
|
2018-10-19 |
2021-08-25 |
Ambrx, Inc. |
Conjugués polypeptidiques d'interleukine-10, dimères de ceux-ci et leurs utilisations
|
EP3679928A1
(fr)
*
|
2019-01-08 |
2020-07-15 |
Atlangram |
Composition pharmaceutique de type gel pour traiter/prevenir une infection
|
CA3128081A1
(fr)
|
2019-02-12 |
2020-08-20 |
Ambrx, Inc. |
Contenant de compositions, procedes et utilisations de conjugues anticorps-agonistes tlr
|
WO2020210533A1
(fr)
*
|
2019-04-12 |
2020-10-15 |
The Regents Of The University Of Michigan |
Copolymères triséquencés et microsphères gélifiantes nano-fibreuses les comprenant
|
WO2020254249A1
(fr)
|
2019-06-21 |
2020-12-24 |
Proqr Therapeutics Ii B.V. |
Administration d'acides nucléiques pour le traitement de troubles auditifs
|
FI4037660T3
(fi)
|
2019-09-30 |
2023-12-14 |
Tolmar International Ltd |
Nestemäiset polymeerikoostumukset ja järjestelmät peptidien pitkäaikaista luovutusta varten aktiivisina farmaseuttisina ainesosina
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
KR20220151202A
(ko)
|
2020-03-11 |
2022-11-14 |
암브룩스, 인코포레이티드 |
인터류킨-2 폴리펩타이드 접합체 및 그의 사용 방법
|
US20230302150A1
(en)
|
2020-08-20 |
2023-09-28 |
Ambrx, Inc. |
Antibody-tlr agonist conjugates, methods and uses thereof
|
AU2022249223A1
(en)
|
2021-04-03 |
2023-10-12 |
Ambrx, Inc. |
Anti-her2 antibody-drug conjugates and uses thereof
|
CN113354823B
(zh)
*
|
2021-06-18 |
2023-03-31 |
四川大学 |
一种用于全降解血管支架的嵌段聚合物及制备方法
|
CN115814146B
(zh)
*
|
2022-11-01 |
2023-12-22 |
山东大学 |
一种仿生凝血机制的止血粉制备方法
|